Suit Filed to Protect Tongjitang’s Xianling Gubao Trademark

SHENZHEN, China--(BUSINESS WIRE)--Tongjitang Chinese Medicines Company (NYSE: TCM), a leading specialty pharmaceutical company focused on the development, manufacturing, marketing and selling of modernized traditional Chinese medicines in China, today announced that it has filed a lawsuit against Jilin Liaoyuan Yulongyadong Pharmaceutical (“Yulongyadong”) for violation of PRC Intellectual Property (“IP”) Protection laws. The action, filed on May 28, 2008 in Guiyang Intermediate People’s Court in China, seeks to prevent Yulongyadong from infringing upon the Company’s trademark by deliberately copying its product, Xianling Gubao.

“Our manufacturing method is a certified trade secret in the PRC, and we are dedicated to protecting the reputation and brand strength of our products. Xianling Gubao is the leading TCM treatment for osteoporosis in China, and we will aggressively push to ensure that the laws governing trademark use are enforced in an attempt to prevent harm to our customers and investors. We are working diligently to ensure that our customers are neither misled nor confused at the point of sale,” said Xiaochun Wang, Tongjitang’s Chief Executive Officer and Chairman.

About Tongjitang Chinese Medicines Company

Tongjitang Chinese Medicines Company, through its operating subsidiaries Tongjitang Pharmaceutical, Tongjitang Distribution, Tongjitang Chain Stores, and Tongjitang Planting, is a vertically integrated and profitable specialty pharmaceutical company focused on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China. Tongjitang’s principal executive offices are located in Shenzhen, China.

Tongjitang’s flagship product, Xianling Gubao, is the leading traditional Chinese medicine for the treatment of osteoporosis in China as measured by sales in Renminbi. In addition to Xianling Gubao, the Company manufactures and markets 10 other modernized traditional Chinese medicine products and 37 western medicines. Please visit www.tongjitang.com for more information.